Evidence map›Paper›PMID 35439267›Full record

ArticlePloS one2022

Hedonic pricing analysis for semen of dairy bulls in Brazil.

Glauco Rodrigues Carvalho, Weslem Rodrigues Faria, Vinícius Pimenta Delgado Ribeiro Nardy, Admir Antonio Betarelli Junior

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Simulation analysis of high-throughput oyster cryopreservation at three scales of production.Aquaculture international : journal of the European Aquaculture Society · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Glauco Rodrigues CarvalhoEmpresa Brasileira de Pesquisa Agropecuária (EMBRAPA), Juiz de Fora, MG, Brazil.
Weslem Rodrigues FariaFaculdade de Economia, Campus Universitário, Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.ORCID 0000-0002-4398-3321
Vinícius Pimenta Delgado Ribeiro NardyFaculdade de Economia, Campus Universitário, Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.ORCID 0000-0002-4461-0244
Admir Antonio Betarelli JuniorFaculdade de Economia, Campus Universitário, Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dairy farming is an important aspect of the Brazilian agricultural sector. The presence of numerous producers has created a large number of jobs in this field, contributing significantly to the rural economy. Artificial insemination (AI), used as one of the main means of reproduction, is increasingly gaining importance in the genetic improvement of animals. Given this scenario, the semen of bulls has become extremely marketable and an important aspect of the animal industry. This study aims to develop a hedonic model for the price of semen doses of dairy bulls based on the information from the main sellers of the product in the Brazilian market. The main findings reveal that there is an additional premium for proven bulls. Semen doses from Gir bulls proved to be more expensive, and the AI firm ALTA has a discount compared to the other firms. From the characteristics obtained in the tests, there is a premium only for the Predicted Transmitting Ability-Milk (volume). The most valued feature found is the dose being sexed, that is, the dose that guarantees the gestation of a female from its use. Semen doses from dead bulls has proved to be more expensive.

Indexed as

Plant BreedingSeedsAnimalsBrazilCattleCosts and Cost AnalysisDairyingFemaleInsemination, ArtificialMaleSemen

Identifiers

PMID35439267
PMCPMC9017886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.